Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4136)
All Articles published online
|
Jun 1, 2004 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang B, Chen JY, Chen DD, Wang GB, Shen P. Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol 2004; 10(11): 1643-1646 [PMID: 15162541 DOI: 10.3748/wjg.v10.i11.1643] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/1643.htm |
| Number | Citing Articles |
| 1 |
Takuji Tanaka, Mayu Tanaka, Takahiro Tanaka, Rikako Ishigamori. Biomarkers for Colorectal Cancer. International Journal of Molecular Sciences 2010; 11(9): 3209 doi: 10.3390/ijms11093209
|
| 2 |
Daniel Fatela-Cantillo, Antonio Fernandez-Suarez, Miguel Alonso Marin Moreno, Juan Jesus Puente Gutierrez, Jose Miguel Diaz Iglesias. Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients. Tumor Biology 2012; 33(3): 825 doi: 10.1007/s13277-011-0304-0
|
| 3 |
Haili Wu, Zongwei Li, Peng Yang, Lichao Zhang, Yongsheng Fan, Zhuoyu Li. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells. Cellular Signalling 2014; 26(11): 2397 doi: 10.1016/j.cellsig.2014.07.024
|
| 4 |
N. P. Voskresenskaya, E. N. Bylinsky. Notable and anniversary dates in biochemistry for 2005. Biochemistry (Moscow) 2005; 70(1): 113 doi: 10.1007/s10541-005-0013-7
|
| 5 |
Sybille Mazurek, C. Bruce Boschek, Ferdinand Hugo, Erich Eigenbrodt. Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology 2005; 15(4): 300 doi: 10.1016/j.semcancer.2005.04.009
|
| 6 |
Adam Rzechonek, Aleksandra Kaminska, Piotr Mamczur, Arkadiusz Drapiewski, Władysław Budzynski. Pathobiology of Pulmonary Disorders. Advances in Experimental Medicine and Biology 2016; 955: 51 doi: 10.1007/5584_2016_92
|
| 7 |
Oh-Hyung Kwon, Tae-Wook Kang, Jeong-Hwan Kim, Mirang Kim, Seung-Moo Noh, Kyu-Sang Song, Hyang-Sook Yoo, Woo-Ho Kim, Zhi Xie, David Pocalyko, Seon-Young Kim, Yong Sung Kim. Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level. Biochemical and Biophysical Research Communications 2012; 423(1): 38 doi: 10.1016/j.bbrc.2012.05.063
|
| 8 |
Filipa Macedo, Kátia Ladeira, Adhemar Longatto-Filho, Sandra F. Martins. Editor’s Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker. European Medical Journal 2018; : 42 doi: 10.33590/emj/10313567
|
| 9 |
Sha Tao, Sabrina Hundt, Ulrike Haug, Hermann Brenner. Sensitivity Estimates of Blood-Based Tests for Colorectal Cancer Detection: Impact of Overrepresentation of Advanced Stage Disease. American Journal of Gastroenterology 2011; 106(2): 242 doi: 10.1038/ajg.2010.393
|
| 10 |
Ranju Ralhan, Leroi V. DeSouza, Ajay Matta, Satyendra Chandra Tripathi, Shaun Ghanny, Siddartha Datta Gupta, Sudhir Bahadur, K. W. Michael Siu. Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry. Molecular & Cellular Proteomics 2008; 7(6): 1162 doi: 10.1074/mcp.M700500-MCP200
|
| 11 |
S. S. Shishkin, L. I. Kovalyov, M. A. Kovalyova. Proteomic studies of human and other vertebrate muscle proteins. Biochemistry (Moscow) 2004; 69(11): 1283 doi: 10.1007/PL00021771
|
| 12 |
M.S. Ismail, Serhiy Semenov, Deirdre McNamara. The utility of faecal and urine biomarkers for small bowel diseases. Current Opinion in Gastroenterology 2021; 37(3): 284 doi: 10.1097/MOG.0000000000000730
|
| 13 |
Poh Kuan Chong, Huiyin Lee, Jianbiao Zhou, Shaw-Cheng Liu, Marie Chiew Shia Loh, Ting Ting Wang, Siew Pang Chan, Duane T. Smoot, Hassan Ashktorab, Jimmy Bok Yan So, Khong Hee Lim, Khay Guan Yeoh, Yoon Pin Lim. ITIH3 Is a Potential Biomarker for Early Detection of Gastric Cancer. Journal of Proteome Research 2010; 9(7): 3671 doi: 10.1021/pr100192h
|
| 14 |
Xinyan Zhang, Fan Yang, Joong-Youn Shim, Kenneth L. Kirk, D. Eric Anderson, Xiaoxin Chen. Identification of arsenic-binding proteins in human breast cancer cells. Cancer Letters 2007; 255(1): 95 doi: 10.1016/j.canlet.2007.03.025
|
| 15 |
Philip D Hardt, Nils Ewald. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Expert Review of Molecular Diagnostics 2008; 8(5): 579 doi: 10.1586/14737159.8.5.579
|
| 16 |
Sanna A. Mulder, Monique E. van Leerdam, Anneke J. van Vuuren, Jan Francke, Albert W. van Toorenenbergen, Ernst J. Kuipers, Rob J. Th. Ouwendijk. Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer. European Journal of Gastroenterology & Hepatology 2007; 19(10): 878 doi: 10.1097/MEG.0b013e3282cfa49c
|
| 17 |
Shao Thing Teoh, Sophia Y. Lunt. Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond. WIREs Systems Biology and Medicine 2018; 10(2) doi: 10.1002/wsbm.1406
|
| 18 |
Wen Meng, Hong-Hong Zhu, Ze-Feng Xu, Shan-Rong Cai, Qi Dong, Qiang-Rong Pan, Shu Zheng, Su-Zhan Zhang. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World Journal of Gastrointestinal Oncology 2012; 4(6): 145-151 doi: 10.4251/wjgo.v4.i6.145
|
| 19 |
Carolin Tonus, Gero Neupert, Markus Sellinger. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World Journal of Gastroenterology 2006; 12(43): 7007-7011 doi: 10.3748/wjg.v12.i43.7007
|
| 20 |
Elżbieta Czub, Karl-Heinz Herzig, Anna Szaflarska-Popławska, Karlheinz Kiehne, Piotr Socha, Halina Woś, Barbara Kamińska, Michal Błaszczyński, Wojciech Cichy, Grażyna Bała, Jacek Brodzicki, Urszula Grzybowska-Chlebowczyk, Jarosław Walkowiak. Fecal pyruvate kinase: A potential new marker for intestinal inflammation in children with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2007; 42(10): 1147 doi: 10.1080/00365520701320513
|
| 21 |
Harsha R. Hathurusinghe, Kolitha S. Goonetilleke, Ajith K. Siriwardena. Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal Malignancy. Annals of Surgical Oncology 2007; 14(10): 2714 doi: 10.1245/s10434-007-9481-x
|
| 22 |
Chi-Lee C. Ho, Michael B. Gilbert, Guillaume Urtecho, Hyoungjoo Lee, David A. Drew, Samuel J. Klempner, Jin S. Cho, Thomas J. Ryan, Naryan Rustgi, Hyuk Lee, Jeeyun Lee, Alexander Caraballo, Marina V. Magicheva-Gupta, Carmen Rios, Alice E. Shin, Yuen-Yi Tseng, Jeremy L. Davis, Daniel C. Chung, Andrew T. Chan, Harris H. Wang, Sandra Ryeom. Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer. Cancer Prevention Research 2024; 17(8): 361 doi: 10.1158/1940-6207.CAPR-23-0449
|
| 23 |
Amir Hossein Aalami, Ali Shahriari, Mohammad Mazaheri, Farnoosh Aalami, Amir Amirabadi, Amirhossein Sahebkar. Diagnostic accuracy of tumor M2-pyruvate kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysis. Clinical Biochemistry 2023; 120: 110652 doi: 10.1016/j.clinbiochem.2023.110652
|
| 24 |
Thian‐Sze Wong, Xiao‐Bing Liu, Ambrose Chung‐Wai Ho, Anthony Po‐Wing Yuen, Raymond Wai‐Man Ng, William Ignace Wei. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. International Journal of Cancer 2008; 123(2): 251 doi: 10.1002/ijc.23583
|
| 25 |
Poh‐Kuan Chong, Huiyin Lee, Marie Chiew Shia Loh, Lee‐Yee Choong, Qingsong Lin, Jimmy Bok Yan So, Khong Hee Lim, Ross Andrew Soo, Wei Peng Yong, Siew Pang Chan, Duane T. Smoot, Hassan Ashktorab, Khay Guan Yeoh, Yoon Pin Lim. Upregulation of plasma C9 protein in gastric cancer patients. PROTEOMICS 2010; 10(18): 3210 doi: 10.1002/pmic.201000127
|
| 26 |
Cristina Herrera-Pariente, Sheyla Montori, Joan Llach, Alex Bofill, Eduardo Albeniz, Leticia Moreira. Biomarkers for Gastric Cancer Screening and Early Diagnosis. Biomedicines 2021; 9(10): 1448 doi: 10.3390/biomedicines9101448
|
| 27 |
Tiantian Zhang, Wei Liu, Li Li, Zou Jue, Chunhua Xu. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion. BMC Pulmonary Medicine 2022; 22(1) doi: 10.1186/s12890-022-02103-x
|
| 28 |
Ponnusamy Kalaiarasan, Naidu Subbarao, Rameshwar NK Bamezai. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics. Journal of Molecular Modeling 2014; 20(9) doi: 10.1007/s00894-014-2447-6
|
| 29 |
Ana Hipólito, Filipa Martins, Cindy Mendes, Filipa Lopes-Coelho, Jacinta Serpa. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.656851
|
| 30 |
Juergen Ervens, Hendrik Fuchs, Volker-Till Niemann, Bodo Hoffmeister. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer. Journal of Cranio-Maxillofacial Surgery 2008; 36(2): 89 doi: 10.1016/j.jcms.2007.08.006
|
| 31 |
Sabrina Hundt, Ulrike Haug, Hermann Brenner. Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2007; 16(10): 1935 doi: 10.1158/1055-9965.EPI-06-0994
|
| 32 |
Yogesh Kumar, Niteen Tapuria, Naveed Kirmani, Brian R. Davidson. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker. European Journal of Gastroenterology & Hepatology 2007; 19(3): 265 doi: 10.1097/MEG.0b013e3280102f78
|
| 33 |
Mark M Aloysius, Abed M Zaitoun, Timothy E Bates, Abdulkader Albasri, Mohammad Ilyas, Brian J Rowlands, Dileep N Lobo. Complete absence of M2-pyruvate kinase expression in benign pancreatic ductal epithelium and pancreaticobiliary and duodenal neoplasia. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-327
|
| 34 |
S. S. Shishkin, L. I. Kovalyov, M. A. Kovalyova. Proteomic studies of human and other vertebrate muscle proteins. Biochemistry (Moscow) 2004; 69(11): 1283 doi: 10.1007/s10541-005-0074-7
|
| 35 |
Zongwei Li, Peng Yang, Zhuoyu Li. The multifaceted regulation and functions of PKM2 in tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2014; 1846(2): 285 doi: 10.1016/j.bbcan.2014.07.008
|
| 36 |
Ponnusamy Kalaiarasan, Bhupender Kumar, Rupali Chopra, Vibhor Gupta, Naidu Subbarao, Rameshwar N. K. Bamezai, Rizwan H. Khan. In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2. PLOS ONE 2015; 10(3): e0120469 doi: 10.1371/journal.pone.0120469
|
| 37 |
Yogesh Kumar, Inigo R. Pinedo, Niteen Tapuria, Abigail Zabron, Brian R. Davidson. A comparison of tumour M2-PK with carcinoembryonic antigen and CA19-9 in patients undergoing liver resection for colorectal metastases. European Journal of Gastroenterology & Hepatology 2008; 20(10): 1006 doi: 10.1097/MEG.0b013e3282f857a7
|
| 38 |
Mohd Askandar Iqbal, Vibhor Gupta, Prakasam Gopinath, Sybille Mazurek, Rameshwar N.K. Bamezai. Pyruvate kinase M2 and cancer: an updated assessment. FEBS Letters 2014; 588(16): 2685 doi: 10.1016/j.febslet.2014.04.011
|
| 39 |
Luca Meoli, Nitin K. Gupta, Nima Saeidi, Courtney A. Panciotti, Sudha B. Biddinger, Kathleen E. Corey, Nicholas Stylopoulos. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(4): E613 doi: 10.1152/ajpendo.00296.2017
|
| 40 |
Gang Wang, Jun-Jie Wang, Rui Guan, Yan Sun, Feng Shi, Jing Gao, Xing-Li Fu. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer. Current Cancer Drug Targets 2019; 19(7): 534 doi: 10.2174/1568009618666181015150138
|
| 41 |
S. Yeluri, B. Madhok, K. R. Prasad, P. Quirke, D. G. Jayne. Cancer’s craving for sugar: an opportunity for clinical exploitation. Journal of Cancer Research and Clinical Oncology 2009; 135(7): 867 doi: 10.1007/s00432-009-0590-8
|
| 42 |
Béla Molnár, Kinga Tóth, Barbara Kinga Barták, Zsolt Tulassay. Plasma methylated septin 9: a colorectal cancer screening marker. Expert Review of Molecular Diagnostics 2015; 15(2): 171 doi: 10.1586/14737159.2015.975212
|
| 43 |
Matt W. Johnson, Susan Maestranzi, Audrey M. Duffy, David H. Dewar, Paul J. Ciclitira, Roy A. Sherwood, John R. Nicholls. Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation. European Journal of Gastroenterology & Hepatology 2009; 21(5): 544 doi: 10.1097/MEG.0b013e3283040cb3
|
| 44 |
Hua‐shan Shi, Dan Li, Jing Zhang, Yong‐sheng Wang, Li Yang, Hai‐long Zhang, Xian‐huo Wang, Bo Mu, Wei Wang, Yu Ma, Fu‐chun Guo, Yu‐quan Wei. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice. Cancer Science 2010; 101(6): 1447 doi: 10.1111/j.1349-7006.2010.01562.x
|
| 45 |
Young‐Kyoung Shin, Byong Chul Yoo, Yong Sang Hong, Hee Jin Chang, Kyung Hae Jung, Seung‐Yong Jeong, Jae‐Gahb Park. Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5‐fluorouracil resistance. ELECTROPHORESIS 2009; 30(12): 2182 doi: 10.1002/elps.200800806
|